Image

Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

Recruiting
13 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The goal of this observational study is to investigate the proportion of Mycobacterium tuberculosis (MTB) infection in school contacts of active tuberculosis (ATB) patients. The main questions it aims to answer are:

  • the proportion of MTB infection among school contacts of ATB patients
  • risk factors related to tuberculosis (TB) infection
  • health economic evaluation of screening strategy

Eligibility

Inclusion Criteria:

  • 13 years old or above;
  • Students in junior middle school, high school and university;
  • Close contact of school active tuberculosis case (e.g. in the same classroom, in the same dormitory);
  • Himself/herself (together with his/her guardian for age under 18 years old) willing to participate in trial and sign informed consent.

Exclusion Criteria:

  • Current clinical or sputum culture confirmed active tuberculosis
  • Have completed a full course of treatment for ATB or LTBI

Study details
    Tuberculosis
    Latent Tuberculosis Infection

NCT06033807

Huashan Hospital

27 January 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.